title: Decision-making under conditions of uncertainty-what can we learn from palivizumab?
authors.affiliation: Department of Primary Health Care, University of Oxford, Oxford, UK. Amanda.Burls@phc.ox.ac.uk
authors.forename: Amanda
authors.initials: A
authors.lastname: Burls
authors.forename: Josie
authors.initials: J
authors.lastname: Sandercock
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000191:economics*; D000998:Antiviral Agents / Q000191:economics*; D006801:Humans; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab